Sort
261,768 grants matching “gene therapy”
Cornell ME/CFS Collaborative Research Center
$1,849,848Maureen R Hanson · Cornell University · U54 · FY2019 · NS
SPORE IN BREAST CANCER
$1,849,494Georgetown University · P50 · FY2001 · CA
THE UCLA CENTER FOR IN VIVO IMAGING IN CANCER BIOLOGY
$1,849,460University Of California Los Angeles · P50 · FY2000 · CA
Plasticity at the Excitatory Synapse
$1,849,317Richard L Huganir · Johns Hopkins University · P50 · FY2017 · MH
Cornell ME/CFS Collaborative Research Center
$1,849,148Maureen R Hanson · Cornell University · U54 · FY2018 · NS
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$1,849,078Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
$1,849,078Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of new antibody-based cancer therapies
$1,849,077Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Oxidation in Inflammation and Cardiovascular Disease
$1,848,931Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
Oxidation in Inflammation and Cardiovascular Disease
$1,848,931Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL
Oxidation in Inflammation and Cardiovascular Disease
$1,848,928Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL
Project-002
$1,848,922Bruce T Lamb · Indiana University Indianapolis · U54 · FY2021 · AG
Maximizing Local Access to Therapeutic Deliveries in Glioblastoma
$1,848,644Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2019 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER
$1,848,429Sloan-Kettering Institute For Cancer Res · P50 · FY2005 · CA
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,848,151Roger L Shapiro · Harvard School Of Public Health · U01 · FY2020 · AI
Regulatory and epigenetic landscapes in biological discovery, diagnostics and disease mechanisms
$1,847,611Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2019 · HG
Advancing next-generation CAR-NK therapies targeting CD5 positive T cell malignancies to the clinic
$1,847,485Katy Rezvani · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$1,847,460Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Topiramate as a Disease Altering Therapy for CSPN
$1,847,422A Gordon Smith · Virginia Commonwealth University · U01 · FY2019 · NS
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,847,127Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$1,846,989William M. Sugden · University Of Wisconsin-Madison · P01 · FY2008 · CA
Gene Therapy Pulmonary &Hematologic Disorders
$1,846,928University Of North Carolina Chapel Hill · P01 · FY2005 · HL
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$1,846,892Walther H Mothes · University Of Utah · U54 · FY2024 · AI
Primary Immune Deficiency Treatment Consortium
$1,846,474Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2021 · AI
Hematopoietic Chimerism after Stem Cell Allografts
$1,846,366Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA